Sovaldi (sofosbuvir) is a prescription drug used in combination with other drugs to treat chronic hepatitis C virus (HCV). It comes as an oral tablet and pellets. It’s usually taken once daily.

Sovaldi (sofosbuvir) can cause side effects that range from mild to serious. More common side effects include fatigue and headache. If side effects from Sovaldi become difficult to tolerate, talk with ...

A federal lawsuit alleging price gouging by the maker of hepatitis C drug Sovaldi mirrors a growing struggle to contain hepatitis C-related workers compensation prescription costs that can reach up to ...

– First Regimen for Patients Awaiting Liver Transplantation to Prevent HCV Recurrence – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food ...

In December 2013, the FDA approved Sovaldi a drug developed by Gilead Sciences that promises to do wonders for patients with hepatitis C. Since then, insurers and the government have grown incredibly ...

NEW YORK/LOS ANGELES (Reuters) - Shocked by the rapid adoption of a new $84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren’t blindsided by other drugs being ...

Oct. 23--Sometimes Jane Blumenfeld feels like if she were in prison, she would have a better chance at getting life-saving drugs to treat her liver disease. Blumenfeld is one of 33,160 in California ...

Individual payers aren't alone in balking at the $84,000 price for Gilead Sciences' new hepatitis C treatment Sovaldi. Now, the leading insurance trade group has joined the soloists, backing their ...

Sovaldi, a newly approved drug to treat Hepatitis C, could see between $5 billion and $9 billion in sales during its first year on the market, one of the largest sales for a new drug’s first year, ...

Sovaldi (sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. Sovaldi comes as oral tablets and oral pellets that are typically taken once per day. The ...